Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
RE purchase
Credit agrmnt [a]
Asset disposition
Quarterly results
CC transcript
|
|
LIFECORE BIOMEDICAL, INC. (LNDC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
SC 13D/A
| Cove Street Capital, LLC reports a 5.2% stake in LIFECORE BIOMEDICAL, INC |
| 06/28/2023 |
SC 13D/A
| 22NW Fund, LP reports a 10% stake in Lifecore Biomedical, Inc. |
| 03/16/2023 |
SC 13D/A
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I reports a 16.6% stake in LIFECORE BIOMEDICAL, INC. |
| 03/07/2023 |
SC 13D/A
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP reports a 17.9% stake in LIFECORE BIOMEDICAL, INC. |
| 01/12/2023 |
SC 13D/A
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP reports a 16.6% stake in LIFECORE BIOMEDICAL, INC. |
| 01/10/2023 |
SC 13D/A
| Legion Partners Asset Management, LLC reports a 10% stake in Lifecore Biomedical, Inc. |
| 12/02/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/20/2022 |
SC 13D/A
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I reports a 12.1% stake in Landec Corporation |
| 08/30/2021 |
SC 13D/A
| Legion Partners Asset Management, LLC reports a 9.9% stake in Landec Corporation |
| 04/20/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/22/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/30/2020 |
SC 13D/A
| Legion Partners Asset Management, LLC reports a 8.2% stake in Landec Corporation |
| 03/03/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/24/2018 |
SC 13D/A
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I reports a 9.7% stake in Landec Corporation |
|
|